Physician profile

Thomas K Fehring

Orthopaedic Surgery · Charlotte, NC

NPI 1134101165

$18,323,415.40

in general payments reported to CMS, 2019-2025

17 companies · $3.0M in 2025

The $3.0M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Royalty Or License$7,750,440.58
Consulting Fee$42,935.78
Travel and Lodging$4,116.78
Food and Beverage$2,031.67

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Depuy Synthes Products, INC. $18,240,671.01 2019-2025 Attune, Reclaim, Pinnacle
Medical Device Business Services, INC. $79,906.74 2019-2025 Attune, Velys, Actis
Zimmer Biomet Holdings, INC. $419.16 2019-2025 Persona
Depuy Synthes Sales INC. $347.14 2019-2021
Smith+Nephew, INC. $325.52 2021-2022
Stryker Corporation $200.87 2025 Mako
Lima USA, INC. $171.37 2019
Intellijoint Surgical INC. $168.35 2024 Intellijoint Hip
Bone Support INC. $162.42 2019
Onkos Surgical, INC. $152.33 2024 Eleos Limb Salvage System
Medacta USA, INC. $147.59 2022
Medtronic, INC. $145.66 2024 Plasmablade(Tm)
Next Science LLC $132.07 2021
Peerless Surgical INC. $124.70 2020
Heron Therapeutics, INC. $123.83 2023 Zynrelef
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Heraeus Medical, LLC. $115.95 2019
Osteoremedies, LLC $100.69 2024 Osteoboost Select 10cc, Biowash Surgical Irrigation, Biobrush

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Thomas K Fehring

$18,323,415.40

in general payments reported 2019-2025

Years
2019-2025
Top company
Depuy Synthes Products, INC.
Context
The $3.0M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).

https://glasscript.com/doctor/51445/thomas-k-fehring

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.